$75MSeries A, 4 November 2025
Funds advancing two bispecific ADC programs into the clinic.
- Amount
- $75M
- Stage
- Series A
- Announced
- 4 November 2025
- Lead
- ABL Bio
- Use of funds
- Funds advancing two bispecific ADC programs into the clinic.
- Checked
- Announced by the company
- Sources
- Neok Bio raises $75M businesswire.com
Neok Bio raises $75M news.crunchbase.com